Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Role of delay discounting in predicting change in HBA1c for individuals with prediabetes.

Epstein LH, Paluch RA, Stein JS, Mellis AM, Quattrin T, Mastrandrea LD, Bree KA, Greenawald MH, Bickel WK.

J Behav Med. 2019 Oct;42(5):851-859. doi: 10.1007/s10865-019-00026-3. Epub 2019 Mar 22.

PMID:
30903441
2.

Chronic oral methylphenidate treatment increases microglial activation in rats.

Carias E, Hamilton J, Robison LS, Delis F, Eiden R, Quattrin T, Hadjiargyrou M, Komatsu D, Thanos PK.

J Neural Transm (Vienna). 2018 Dec;125(12):1867-1875. doi: 10.1007/s00702-018-1931-z. Epub 2018 Sep 20.

3.

Hospitalist Medicine-Chairs' Perspective of Specialty Status and Training Requirements.

Clapp DW, Quattrin T, Jacobs RF, Opipari VC.

J Pediatr. 2018 Feb;193:4-8.e1. doi: 10.1016/j.jpeds.2017.11.049. No abstract available.

PMID:
29389453
4.

Cost-effectiveness of Family-Based Obesity Treatment.

Quattrin T, Cao Y, Paluch RA, Roemmich JN, Ecker MA, Epstein LH.

Pediatrics. 2017 Sep;140(3). pii: e20162755. doi: 10.1542/peds.2016-2755.

5.

The Promise and Opportunities for Screening and Treating Childhood Obesity: USPSTF Recommendation Statement.

Quattrin T, Wilfley DE.

JAMA Pediatr. 2017 Aug 1;171(8):733-735. doi: 10.1001/jamapediatrics.2017.1604. No abstract available.

PMID:
28632843
6.

Weight trajectory of youth with new-onset type 1 diabetes comparing standard and enhanced dietary education.

Majumdar I, Bethin K, Quattrin T.

Endocrine. 2015 May;49(1):155-62. doi: 10.1007/s12020-014-0469-6. Epub 2014 Oct 31.

PMID:
25358449
7.

Treatment outcomes of overweight children and parents in the medical home.

Quattrin T, Roemmich JN, Paluch R, Yu J, Epstein LH, Ecker MA.

Pediatrics. 2014 Aug;134(2):290-7. doi: 10.1542/peds.2013-4084.

8.

Methylphenidate decreases fat and carbohydrate intake in obese teenagers.

Danilovich N, Mastrandrea LD, Cataldi L, Quattrin T.

Obesity (Silver Spring). 2014 Mar;22(3):781-5. doi: 10.1002/oby.20574. Epub 2013 Dec 3.

9.

Efficacy of family-based weight control program for preschool children in primary care.

Quattrin T, Roemmich JN, Paluch R, Yu J, Epstein LH, Ecker MA.

Pediatrics. 2012 Oct;130(4):660-6. doi: 10.1542/peds.2012-0701. Epub 2012 Sep 17.

10.

Testosterone concentrations in young pubertal and post-pubertal obese males.

Mogri M, Dhindsa S, Quattrin T, Ghanim H, Dandona P.

Clin Endocrinol (Oxf). 2013 Apr;78(4):593-9. doi: 10.1111/cen.12018.

11.

Screening obese students for acanthosis nigricans and other diabetes risk factors in the urban school-based health center.

Rafalson L, Eysaman J, Quattrin T.

Clin Pediatr (Phila). 2011 Aug;50(8):747-52. doi: 10.1177/0009922811404698.

PMID:
21727074
12.

Does the dopamine transporter protein allele predict growth hormone testing results or response to growth hormone therapy?

Daniel M, Mastrandrea LD, Salis RJ, Erbe R, Quattrin T.

Endocrine. 2010 Apr;37(2):361-4. doi: 10.1007/s12020-010-9313-9. Epub 2010 Mar 6.

PMID:
20960275
13.

Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study.

Mastrandrea L, Yu J, Behrens T, Buchlis J, Albini C, Fourtner S, Quattrin T.

Diabetes Care. 2009 Jul;32(7):1244-9. doi: 10.2337/dc09-0054. Epub 2009 Apr 14.

14.
15.

Inhaled insulin: a novel and non-invasive way for insulin administration?

Quattrin T.

Curr Drug Saf. 2006 May;1(2):151-8.

PMID:
18690926
16.

Young women with type 1 diabetes have lower bone mineral density that persists over time.

Mastrandrea LD, Wactawski-Wende J, Donahue RP, Hovey KM, Clark A, Quattrin T.

Diabetes Care. 2008 Sep;31(9):1729-35. doi: 10.2337/dc07-2426. Epub 2008 Jun 30.

17.

Diminished insulin resistance with weight loss in severely overweight youth.

Roemmich JN, Liu EY, Rogol AD, Epstein LH, Quattrin T.

Metab Syndr Relat Disord. 2004 Fall;2(3):160-8. doi: 10.1089/met.2004.2.160.

PMID:
18370681
18.

Development and validation of the WEll-being and Satisfaction of CAREgivers of Children with Diabetes Questionnaire (WE-CARE).

Cappelleri JC, Gerber RA, Quattrin T, Deutschmann R, Luo X, Arbuckle R, Abetz L.

Health Qual Life Outcomes. 2008 Jan 18;6:3. doi: 10.1186/1477-7525-6-3.

19.

Detecting overweight children in primary care: do national data reflect the typical urban practice?

Sutu E, Crespo CJ, Shine B, Doshi A, Quattrin T.

J Fam Pract. 2006 Nov;55(11):976-80.

PMID:
17090358
20.

Clinical evaluation of inhaled insulin.

Mastrandrea LD, Quattrin T.

Adv Drug Deliv Rev. 2006 Oct 31;58(9-10):1061-75. Epub 2006 Aug 17. Review.

PMID:
17070613
21.

Obese children who are referred to the pediatric endocrinologist: characteristics and outcome.

Quattrin T, Liu E, Shaw N, Shine B, Chiang E.

Pediatrics. 2005 Feb;115(2):348-51.

PMID:
15687443
22.

Basal growth hormone concentrations in blood and the risk for prostate cancer: a case-control study.

Fuhrman B, Barba M, Schünemann HJ, Hurd T, Quattrin T, Cartagena R, Carruba G, Muti P.

Prostate. 2005 Jul 1;64(2):109-15.

PMID:
15666390
23.

Inhaled insulin: recent advances in the therapy of Type 1 and 2 diabetes.

Quattrin T.

Expert Opin Pharmacother. 2004 Dec;5(12):2597-604. Review.

PMID:
15571476
24.

Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.

Quattrin T, Bélanger A, Bohannon NJ, Schwartz SL; Exubera Phase III Study Group.

Diabetes Care. 2004 Nov;27(11):2622-7.

PMID:
15504996
25.

Does low bone mineral density start in post-teenage years in women with type 1 diabetes?

Liu EY, Wactawski-Wende J, Donahue RP, Dmochowski J, Hovey KM, Quattrin T.

Diabetes Care. 2003 Aug;26(8):2365-9.

PMID:
12882863
26.

Fasting glucose is a risk factor for breast cancer: a prospective study.

Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schünemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F.

Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1361-8.

28.

Improvement of HbA1c without increased hypoglycemia in adolescents and young adults with type 1 diabetes mellitus treated with recombinant human insulin-like growth factor-I and insulin. rhIGF-I in IDDM Study Group.

Quattrin T, Thrailkill K, Baker L, Kuntze J, Compton P, Martha P; rhIGF-I in IDDM Study Group.

J Pediatr Endocrinol Metab. 2001 Mar;14(3):267-77.

PMID:
11308044
29.

Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives.

Maclaren N, Lan M, Coutant R, Schatz D, Silverstein J, Muir A, Clare-Salzer M, She JX, Malone J, Crockett S, Schwartz S, Quattrin T, DeSilva M, Vander Vegt P, Notkins A, Krischer J.

J Autoimmun. 1999 Jun;12(4):279-87.

PMID:
10330299
30.

Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group.

Thrailkill KM, Quattrin T, Baker L, Kuntze JE, Compton PG, Martha PM Jr.

Diabetes Care. 1999 Apr;22(4):585-92.

31.

Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.

Thrailkill K, Quattrin T, Baker L, Litton J, Dwigun K, Rearson M, Poppenheimer M, Kotlovker D, Giltinan D, Gesundheit N, Martha P Jr.

J Clin Endocrinol Metab. 1997 Apr;82(4):1181-7.

PMID:
9100593
32.

Dual hormonal replacement with insulin and recombinant human insulin-like growth factor I in IDDM. Effects on glycemic control, IGF-I levels, and safety profile.

Quattrin T, Thrailkill K, Baker L, Litton J, Dwigun K, Rearson M, Poppenheimer M, Giltinan D, Gesundheit N, Martha P Jr.

Diabetes Care. 1997 Mar;20(3):374-80.

PMID:
9051390
33.

Age and family relationship accentuate the risk of insulin-dependent diabetes mellitus (IDDM) in relatives of patients with IDDM.

Cantor AB, Krischer JP, Cuthbertson DD, Schatz DA, Riley WJ, Malone J, Schwartz S, Quattrin T, Maclaren NK.

J Clin Endocrinol Metab. 1995 Dec;80(12):3739-43.

PMID:
8530627
34.

Hematuria in children and adolescents with insulin-dependent diabetes mellitus.

Waz WR, Quattrin T, Feld LG.

J Diabetes Complications. 1995 Jul-Sep;9(3):194-7.

PMID:
7548985
35.

Microalbuminuria in an adolescent cohort with insulin-dependent diabetes mellitus.

Quattrin T, Waz WR, Duffy LC, Sheldon MW, Campos SP, Albini CH, Feld LG.

Clin Pediatr (Phila). 1995 Jan;34(1):12-7.

PMID:
7720322
36.

Urinary insulin-like growth factor-II excretion in healthy infants and children with normal and abnormal growth.

Quattrin T, Albini CH, Sportsman C, Shine BJ, MacGillivray MH.

Pediatr Res. 1993 Oct;34(4):435-8.

PMID:
8255673
37.

Serum creatinine, height, and weight do not predict glomerular filtration rate in children with IDDM.

Waz WR, Quattrin T, Feld LG.

Diabetes Care. 1993 Aug;16(8):1067-70.

PMID:
8375234
38.

Urinary growth hormone and insulin-like growth factor I. Effects of growth-hormone injection schedule.

Albini CH, Quattrin T, Mills B, Sherman B, Johanson A, MacGillivray MH.

Clin Pediatr (Phila). 1992 Sep;31(9):542-5.

PMID:
1468171
39.

Urinary excretion of IGF-I and growth hormone in children with IDDM.

Quattrin T, Albini CH, Reiter EO, Mills BJ, MacGillivray MH.

Diabetes Care. 1992 Apr;15(4):490-4.

PMID:
1499463
40.

Diagnostic significance of urinary growth hormone measurements in children with growth failure: correlation between serum and urine growth hormone.

Albini CH, Sotos J, Sherman B, Johanson A, Celniker A, Hopwood N, Quattrin T, Mills BJ, MacGillivray MH.

Pediatr Res. 1991 Jun;29(6):619-22.

PMID:
1866220
41.

Prognostic signs in the evolution of premature thelarche by discriminant analysis.

Tenore A, Franzese A, Quattrin T, Sandomenico ML, Aloi G, Gallo P, Mariano A, Di Maio S.

J Endocrinol Invest. 1991 May;14(5):375-81.

PMID:
1908492
42.

Management of male pseudohermaphroditism: a case report spanning twenty-one years.

Quattrin T, Aronica S, Mazur T.

J Pediatr Psychol. 1990 Dec;15(6):699-709.

PMID:
2283575
43.

Comparison of urinary growth hormone and IGF-I excretion in small- and appropriate-for-gestational-age infants and healthy children.

Quattrin T, Albini CH, Mills BJ, MacGillivray MH.

Pediatr Res. 1990 Sep;28(3):209-12.

PMID:
2235116
44.

Quantitation of urinary somatomedin-C and growth hormone in preterm and fullterm infants and normal children.

Quattrin T, Albini CH, Cara JF, Vandlen RL, Mills BJ, MacGillivray MH.

J Clin Endocrinol Metab. 1988 Apr;66(4):792-7.

PMID:
3346357
45.

Quantitation of urinary growth hormone in children with normal and abnormal growth.

Albini CH, Quattrin T, Vandlen RL, MacGillivray MH.

Pediatr Res. 1988 Jan;23(1):89-92.

PMID:
3340452
46.

Quantitation of urinary somatomedin-C in children with normal and abnormal growth.

Quattrin T, Albini CH, Vandlen RL, MacGillivray MH.

J Clin Endocrinol Metab. 1987 Dec;65(6):1168-71.

PMID:
3680479
47.

Vertical transmission of the neurofibromatosis/Noonan syndrome.

Quattrin T, McPherson E, Putnam T.

Am J Med Genet. 1987 Mar;26(3):645-9.

PMID:
3105315

Supplemental Content

Loading ...
Support Center